Geneva, March 24 -- Faron Pharmaceuticals Oy has filed a patent application for Recombinant Clever-1 Fragment, Method for Producing Recombinant Clever-1 Fragment, and Uses Thereof. This invention was developed by Hollmén Maija-leena, Prince Stuart and Bendes Ábris. The patent application number is WO2025FI50236 20250509. Th..